project id: TCGA-HNSC; case submitter id: TCGA-IQ-A61O; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.19; rna integrity number: 8.2; age at index: 43; days to birth: -15920; days to death: 421; ethnicity: hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1969; age at diagnosis: 15920; ajcc clinical m: MX; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 360.0; icd 10 code: C01; last known disease status: not reported; morphology: 8074/3; primary diagnosis: Squamous cell carcinoma, spindle cell; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Oropharynx, NOS; synchronous malignancy: No; tissue or organ of origin: Oropharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 288; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-IQ-A61O-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;